the ethics of their use, with many of the present arguments being primarily philosophically-based. Given the magnitude of placebo analgesic effects and the frequency of physician-administered placebos, the present study empirically investigated the acceptability of an analgesic placebo treatment among lay individuals.
A total of 103 participants (M age = 22.67, SD = 4.57) completed a web-based study examining placebo attitudes and consequences by responding to vignettes depicting patients receiving a placebo analgesic. We experimentally manipulated 1)
placebo treatment instructions (level of deception), 2) treatment outcome, and 3)
patients' pain severity. Participants rated vignettes on outcome measures of deception, physician-patient relationship, and patient mood. Participants then characterized a range of placebo acceptability through ratings of deceptiveness, effectiveness, and negative consequences.
Results showed that placebos described as -medication shown to be a powerful analgesic in some people‖ were equally deceptive as those described as -standard drug treatment.‖ Placebo deceptiveness was primarily determined by the nature of its administration. However, ratings of patient mood and physician approval were determined as much by treatment instruction as by treatment outcome. Furthermore, consistent with recent placebo studies, negative mood ratings were largely unaffected by placebo administration if they resulted in analgesia, indicating that an analgesic response mitigated the negative consequences of deceptive administration. The use and consequences of deception are focal points of the placebo ethics debate. 13, 23 Despite the claims of a number of ethicists, empirical evidence of the negative consequences of deception remains inconsistent. 17 To date, the literature pertaining to placebo acceptability and deception has been based largely on philosophical and theoretical tenants, with relatively few data-driven empirical studies.
2, 5, 13, 18, 21 Chung et al. 7 found that placebo for pain relief caused no negative effects on mood or placebo responses even after the use of placebo was revealed to participants.
Another study by Martin & Katz 20 found no significant differences in mood nor the magnitude of placebo analgesia between two groups differentiated by whether or not they were informed of potential deception while consenting to study participation. A recent investigation regarding patients' attitudes about the clinical use of placebos found that patients were generally open to receiving placebo interventions, though they lacked understanding about how placebos worked. 6 The current study attempted to expand upon the sparse empirical literature on the acceptability of placebo interventions for pain. In this vignette analog study, systematic manipulation of 1) the instructions used in administering the placebo (hypothesized to represent a range of deceptiveness), 2) the outcome of the treatment, and 3) the progressiveness/severity of the patients' pain were used to examine how these factors influence the acceptability and ethics of a placebo treatment for pain. We hypothesized that placebo in scenarios in which patients were completely deceived by treatment instructions, received worse treatment outcomes, and experienced a more serious pain condition would be rated as less acceptable; conversely, placebo in scenarios in which patients were randomly assigned to treatment, had reduced pain outcomes, and experienced a less serious pain condition would be rated as more acceptable. There were two levels of pain progressiveness. The patients in each vignette were being treated for either non-progressive pain/pain that is stable (NP) or progressive/worsens/debilitating pain (PP). The descriptors -pain that is stable‖ and -worsens/debilitating pain‖ were used to add clarify non-progressive and progressive pain, respectively. Although participants may have been responding to any of the descriptors in responding to a vignette, for purposes of simplicity only the terms nonprogressive pain and progressive pain will be used in this manuscript.
There were three levels of treatment instructions. For the -enhanced placebo‖ (EP) instruction, the patients were told they would receive -a medication that has shown to be a powerful analgesic in some people.‖ This suggestion is similar to that utilized in previous placebo analgesia studies and has been proposed to be an ethically permissible placebo suggestion. 27, 33, 34 For the full deception (FD) instruction, patients were told by their physician that they had -received a standard drug treatment‖ for their pain. For the random assignment (RA) instruction, patients were informed by their physician that they would receive either a -standard drug treatment or a placebo treatment‖ for their pain. These instructions were intended to be an experimental manipulation of degree of deception. The purpose of this manipulation was to study/investigate the individual differences in the consequences of learning that one has been deceived.
There were three levels for outcome/effectiveness of the placebo treatment. Upon completion of the intervention, the patients' pain either improved/got better (B), was unaffected by the treatment (NC), or worsened (W).
Part 2: Acceptability Survey
The Acceptability Survey, the final section of the study, was completely distinct from the Placebo Vignettes in structure and response format. Participants were asked to rate three levels of acceptability regarding placebo use: an entirely unacceptable placebo (EU), a marginally acceptable placebo (MA), and an entirely acceptable placebo (EA). Each level of acceptability was rated using a combination of three separate Visual Analogue Scales (VAS) (0-100) measuring the relative contribution of each of the following variables: deceptiveness of the placebo (-not at all deceptive‖ to -completely deceptive‖), effectiveness of the placebo (-not at all effective‖ to -completely effective‖), and severity/negative consequences of placebo (-not at all severe‖ to -most severe imaginable‖) ( Table 2-1) .
Following the VAS ratings, participants were asked to respond either -agree‖ or -disagree‖ to the following two statements: 1) -I think that placebo for pain is never acceptable‖ and 2) -I think that placebo for pain is always acceptable.‖
Measures

Visual analogue scales (vas). VAS measurements were used in the Placebo
Vignettes and in the Acceptability Survey. After reading a vignette, VAS ratings were Character); (6) rating of how angry the patient would be if they knew they had received a placebo (Pt. Anger); (7) how anxious the patient would be if they knew they had received a placebo (Pt. Anxiety); (8) how depressed the patient would be if they knew they had received a placebo (Pt. Depression). Previous research in our lab has shown that pain related negative emotions, such as anger, depression, and anxiety, typically load highly on to a latent negative mood factor; thus it was hypothesized that these three outcomes measure would load highly on to a latent negative mood factor.
14, 28
Furthermore we had no separate a priori hypotheses about individual mood measures.
It should be noted that in the Placebo Vignettes, deception is used a both an independent variable (i.e. by proxy through treatment instruction levels) and a dependent measure (i.e. Extent Deception VAS ratings).
For Acceptability Survey VAS descriptions refer to the previous section and Table   2 -1.
Statistical Analyses Principle Axis Factoring
The -extent deception‖ question was of interest as an individual question and intended to be analyzed separately a priori. on the second factor, with factor loadings of .568, .787, and .728, respectively. These three outcome variables each had negative loadings on the first factor, suggesting a negative correlation between the two latent factors. The corresponding factor regression scores were used to create a -Physician Approval‖ factor from the first latent factor and a -Negative Mood‖ factor from the second latent factor. These two factors, in addition to the Extent Deception measure, were used in subsequent Placebo Vignettes analyses.
The extraction of the Negative Mood factor supports previous research findings in our laboratory showing mood variables correlate highly, signifying a latent negative mood construct.
Factorial Repeated-Measures Analyses of Variance (ANOVA)
Three separate 3 x 3 x 2 (instructions x outcome x progressiveness) repeated- Note: Underlined text will change depending on The scenario. The options for pain progressiveness status, treatment instructions, and treatment outcome are displayed below the vignette box.
CHAPTER 3 RESULTS
Overall means and standard deviations for Placebo Vignette outcome measures can be found in Table 3 -1.
Extent Deception Extent Deception Main Effects
The following results were based upon this individual Placebo Vignettes outcome Deception measure (Table 3-2) . Participants rated vignettes as more deceptive when patients received enhanced placebo and full deception instructions (compared to random assignment), when they experienced pain worsening outcomes (compared to pain Improvement and no change in pain), and when they had progressive pain. No significant differences were found for deception ratings between full deception and enhanced placebo instructions, or between pain improvement and pain unaffected by treatment outcomes.
Extent Deception Interactions
A progressiveness x instructions interaction (F(2,204) = 4.27, p = .015, ηp 2 = .04) illustrated that differences in deceptiveness ratings between progressive and non- .08) were found for Physician Approval factor ratings (Table 3- 
2). Similar to Extent
Deception results, there were lower approval ratings when patients received full deception and enhanced placebo instructions (compared to random assignment) and when they had progressive pain, with results showing no significant differences between full deception and enhanced placebo instructions (F(1,102) = .04, p = .835).
Physician Approval Interactions
There were no significant interactions for the Physician Approval measure (Table   3 -2).
Negative Mood Factor Negative Mood Main Effects
The (Table 3 -2). Significant graded increases in Negative Mood ratings were seen from random assignment, to enhanced placebo, to full deception instructions.
Similarly, results showed graded increases in Negative Mood ratings from pain improvement, to pain unchanged, to pain worsening outcomes. Patients were rated as having more negative mood when experiencing progressive pain.
Negative Mood Interactions
A progressiveness x instructions interaction revealed that differences in Negative
Mood ratings for progressive and non-progressive pain only existed for full deception and random assignment conditions, (F(1,102) = 5.69, p = .019, ηp 2 = .05). There were a number of significant contrasts ( 
Acceptability Survey
Results (Table 3 -3 and Figure 3-1) indicated that an entirely acceptable placebo was characterized by low ratings of deceptiveness, high rating of effectiveness, and low ratings of negative consequences; an entirely unacceptable placebo had high ratings of deceptiveness, low ratings of effectiveness, and high ratings of negative consequences; a marginally acceptable placebo was characterized by moderate ratings of deceptiveness, effectiveness, and negative consequences.
Responses to two acceptability statements indicated that 78.1% of participants disagreed with the statement -Placebo for pain is never acceptable‖ and 9% agreed with the statement -Placebo for pain was always acceptable.‖ The aim of the present study was to assess attitudes towards the use of a placebo treatment for pain in addition to evaluating the contributions of specific factors in determining placebo acceptability. Our primary aim was to test the effects of level of deception, the effectiveness of the placebo, and the severity (progressiveness) of the pain condition on attributes about provider, mood, and perceived placebo acceptability.
Our results supported our hypotheses by demonstrating a number of main effects across the three vignette manipulations -instructions regarding placebo administration, placebo treatment outcome, and progressiveness of the patient's pain. Although not a priori hypothesized, a number of interactions between these factors were observed.
Overall, participants rated placebo interventions as significantly more acceptable when patients were randomly assigned to a treatment group, when the treatment resulted in an improvement in pain, and when patients' pain was non-progressive. Conversely, vignettes were rated as significantly less acceptable overall when placebo administration entailed full deception, when the treatment culminated in a worse pain outcome, and when patients had progressive pain.
Extent Deception
Whereas the effects of progressiveness of pain condition and placebo treatment outcome were statistically significant, ratings regarding extent of deception were largely influenced by whether or not patients were randomly assigned to a placebo treatment, with full deception and enhanced placebo instructions rated as similarly deceptive.
Overall, graded increases in deception were observed from pain that improved, to pain remaining unaffected by treatment, to pain that worsened as a result of placebo for both full deception and enhanced placebo and instructions. An interaction indicated that when patients were told they would be randomly assigned to placebo treatment, pain improvement was rated as more deceptive than when pain was unaffected by placebo treatment, suggesting that participants may have had less trust in the nature of the patients' pain relief when fully aware that the outcome may have resulted from a placebo. Consistent with results from recent placebo studies, 6, 9 this finding may reflect misunderstanding among those in the general public about placebo mechanisms and effectiveness. Although the present interaction and a number of the significant interactions had small effect sizes, they represent directions for future investigations examining the relationships between placebo factors.
Physician Approval
Deterioration of the physician -patient relationship, a concern traditionally purported by ethicists as an argument against placebo use 22 , is a stance that has received sparse empirical examination. Our findings indicate that physician approval ratings were characterized by large effects of treatment instructions and treatment outcome. Whereas the effect of instructions was largely determined by whether or not patients were randomly assigned to receive the placebo, treatment outcome was primarily influenced by whether patients' pain improved upon treatment (placebo) completion. While these findings support assertions that physician approval is highly dependent on deceptiveness of placebo administrations, they also indicate that beneficial treatment outcomes may influence the physician -patient relationship.
Negative Mood
Interactions between outcome, treatment instructions, and pain progressiveness influenced negative mood. The increase in negative mood seen when patients had progressive pain (compared to non-progressive pain) was significantly greater when patients received the full deception instructions than when they received enhanced placebo instructions. This finding is important because it demonstrates that, in contrast to being fully deceived in placebo administration, patients mood ratings were virtually unaffected by their pain status for the enhanced placebo condition. Differences in negative mood among the three treatment outcomes were generally greater for enhanced placebo and full deception than for random assignment, again suggesting that a sophisticated understanding of placebo mechanisms has not reached the lay public. Negative mood results support the findings from Chung et al. 7 and Martin and 20 , indicating that there were relatively minor effects on mood ratings resulting from the revelation of a placebo analgesia response. There were a number of significant interactions and associated contrasts for this measure, the largest of which showed higher negative mood ratings for randomly assigned progressive pain patients whose pain remained unaffected by the placebo treatment. This is an interesting finding, suggesting that even though the instruction set was perceived as low in deception, a poor treatment response was still potentially harmful (worsened mood).
Acceptability Survey
Acceptability Survey findings illustrated that an entirely acceptable placebo consisted of low ratings of deceptiveness and severity/negative consequences, with , and that nearly 80% of our sample believed there were instances when placebo for pain was acceptable, further studies are needed to determine the lowest tolerable levels of deceptiveness and negative consequences necessary to constitute an acceptable placebo.
Implications
Findings from this study provide empirical evidence that a degree of deception is perceived in placebo administration. This was true even when an accurate, but arguably deceptive, enhanced placebo description was used. Perception of treatment deception was strongly determined by method of placebo administration -specifically whether or not patients were randomly assigned to receive a placebo or a standard treatment for their pain. Interestingly, this was contrasted for ratings of physician-patient relationship and negative mood, both of which were almost equally influenced by deceptiveness and treatment outcome. There were limitations to the generalizability of this study. Although participants were asked to respond to vignettes as if they were the patients, the ratings from a primarily undergraduate sample may not have been representative of a pain patient population. 16 However, it is important to remember that these participants are, and will be consumers of medical services. Furthermore, the sample also is representative of a voting public that will in part determine policies about placebo use. Finally, we acknowledge that this study was designed with a priori hypotheses about Placebo
Vignette main effects and not their interactions, thus making the interpretation of the interactions a somewhat speculative venture. While recognizing our interpretive limitations, we fully believe this design was necessary and warranted given the lack of empirical data on said interactions, and we expect this examination to serve as the rational for future hypothesis driven designs.
Conclusions
The results of the present study illustrate that for the perception of placebo treatments for pain, physician-patient relationships and negative mood are dependent as much by the deceptiveness of a placebo administration as by the outcome of the intervention. This is significant as the importance of treatment outcome and associated placebo efficacy is largely overshadowed in the placebo ethics literature by issues of deceptiveness. Although the manner in which placebos are administered strongly determines the degree of treatment deceptiveness, our results confirm the findings of previous studies that a considerable degree of deception and negative consequences can be tolerated in people's conceptualization of an acceptable placebo. While the largest effects were predicted and seen for deception and treatment outcome, our results show that significant interactions between these factors and pain severity do differentially affect placebo acceptability, suggesting further investigations into these relationships is not only warranted but necessary. Studies designed to instruct participants on the mechanisms of placebo might yield greater placebo acceptability from instruction sets that highlight that placebo effects are well characterized, physiologically active effects. 
